Zobrazeno 1 - 10
of 125
pro vyhledávání: '"Eugenio, Cersosimo"'
Autor:
Muhammad A Abdul-Ghani, Ralph A DeFronzo, Aurora Merovci, Brittany Finley, Andrea Hansis-Diarte, Sivaram Neppala, Eugenio Cersosimo, Curtis Triplitt
Publikováno v:
BMJ Open Diabetes Research & Care, Vol 12, Iss 5 (2024)
Introduction Low carbohydrate ketogenic diets have received renewed interest for the treatment of obesity and type 2 diabetes. These diets promote weight loss, improve glycemic control, and reduce insulin resistance. However, whether the improvements
Externí odkaz:
https://doaj.org/article/3e0ca4efae6e484887d6c32744921b0f
Autor:
Anthony H. Cincotta, Eugenio Cersosimo, Mariam Alatrach, Michael Ezrokhi, Christina Agyin, John Adams, Robert Chilton, Curtis Triplitt, Bindu Chamarthi, Nicholas Cominos, Ralph A. DeFronzo
Publikováno v:
International Journal of Molecular Sciences, Vol 23, Iss 16, p 8851 (2022)
Bromocriptine-QR is a sympatholytic dopamine D2 agonist for the treatment of type 2 diabetes that has demonstrated rapid (within 1 year) substantial reductions in adverse cardiovascular events in this population by as yet incompletely delineated mech
Externí odkaz:
https://doaj.org/article/a12bfaed54a74d00bcefdb4e1daeb71c
Autor:
Ricardo J. Samms, Christine C. Cheng, Marcel Fourcaudot, Sami Heikkinen, Ahmed Khattab, John Adams, Eugenio Cersosimo, Curtis Triplitt, Curtis Puckett, Kostas Tsintzas, Andrew. C. Adams, Muhammad A. Abdul-Ghani, Ralph A. DeFronzo, Luke Norton
Publikováno v:
American journal of physiology. Endocrinology and metabolism. 323(2)
Fibroblast growth factor 21 (FGF21) is increased acutely by carbohydrate ingestion and is elevated in patients with type 2 diabetes (T2D). However, the physiological significance of increased FGF21 in humans remains largely unknown. We examined wheth
Pioglitazone reduces epicardial fat and improves diastolic function in patients with type 2 diabetes
Autor:
Alexander J. Moody, Marjorie Molina‐Wilkins, Geoffrey D. Clarke, Aurora Merovci, Carolina Solis‐Herrera, Eugenio Cersosimo, Robert J. Chilton, Patricia Iozzo, Amalia Gastaldelli, Muhammad Abdul‐Ghani, Ralph A. DeFronzo
Publikováno v:
Diabetes, obesitymetabolismREFERENCES.
To examine the effect of pioglitazone on epicardial (EAT) and paracardial adipose tissue (PAT) and measures of diastolic function and insulin sensitivity in patients with type 2 diabetes mellitus (T2DM).Twelve patients with T2DM without clinically ma
Autor:
null Alexander J Moody, null Marjorie Molina‐Wilkins, null Geoffrey D Clarke, null Aurora Merovci, null Carolina Solis‐Herrera, null Eugenio Cersosimo, null Robert J Chilton, null Patricia Iozzo, null Amalia Gastaldelli, null Muhammad Abdul‐Ghani, null Ralph A. DeFronzo
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0074731bda10b0dd2619fb8d1d8c4fe7
https://doi.org/10.1111/dom.14885/v3/response1
https://doi.org/10.1111/dom.14885/v3/response1
Autor:
XI CHEN, CAROLINA SOLIS-HERRERA, DEVJIT TRIPATHY, ANDREA A. HANSIS-DIARTE, ROBERT CHILTON, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Publikováno v:
Diabetes. 71
We previously have shown that both acute and chronic SGLT-2 inhibition increases endogenous glucose production (EGP) . However, the organ - liver versus kidney - responsible for the increase in EGP has not been identified. We assessed the effect of a
Autor:
ALBERTO O. CHAVEZ VELAZQUEZ, EMAD ALI, AURORA MEROVCI, CHRISTINA AGYIN, TOMOKO TERASAWA, MUHAMMAD ABDUL-GHANI, CURTIS L. TRIPLITT, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Publikováno v:
Diabetes. 71
Treating PreDM with medications that target specific pathophysiologic defects can slow/prevent the progression to type 2 diabetes mellitus (T2DM) . While the preventive effects of Pioglitazone (PIO) and Metformin (MET) previously have been described
Autor:
CAROLINA SOLIS-HERRERA, YUEJUAN QIN, HENRI HONKA, ALEXANDER MOODY, GEOFFREY D. CLARKE, CURTIS L. TRIPLITT, EUGENIO CERSOSIMO, RALPH A. DEFRONZO
Publikováno v:
Diabetes. 71
Mechanism (s) responsible for the cardiac benefits of SGLT2 inhibitors remain unknown. Aim: To examine the effect of increased ketone concentration (with infusion of beta-hydroxybutyrate [BOHB]) on left ventricular (LV) function and myocardial glucos
Autor:
MARYAM BARKHORDARIAN, CURTIS L. TRIPLITT, CAROLINA SOLIS-HERRERA, JOHN M. ADAMS, RALPH A. DEFRONZO, EUGENIO CERSOSIMO
Publikováno v:
Diabetes. 71
Aim: To examine the renal hemodynamic effects of SGLT-2i therapy in type 2 diabetes patients [T2D]. Design & Methods: T2D (n=20) with normal GFR measured with 24-hour creatinine clearance [CrCl>100ml/min/1.73m2], who were not receiving ACEi or ARB, h
Publikováno v:
Brazilian Journal of Nephrology, Vol 36, Iss 1, Pp 80-92 (2014)
The importance of the kidney in glucose homeostasis has been recognized for many years. Recent observations indicating a greater role of renal glucose metabolism in various physiologic and pathologic conditions have rekindled the interest in renal gl
Externí odkaz:
https://doaj.org/article/710e75731dba479d828595f806084137